ZYKADIA®
(zye kaye' dee ah)
(Ceritinib)

Chemotherapy 

ZYKADIA®
(zye kaye' dee ah)
(Ceritinib)

Chemotherapy

What is ZYKADIA (Ceritinib)?

ZYKADIA is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

It is not known if ZYKADIA is safe and effective in children.

What is the most important information I should know about ZYKADIA?

ZYKADIA can cause serious side effects. These serious side effects include:

How should I take ZYKADIA ?

Nucleic Acid Diagnostic kit

Important Safety Information

Ask your healthcare provider if you do not know.

What should I tell my healthcare provider before taking ZYKADIA?

Before you take ZYKADIA, tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements also about all of your medical conditions, including if you:

Available 24/7
Experiencing
symotoms that
concern you

General information about ZYKADIA

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ZYKADIA for a condition for which it was not prescribed. Do not give it to other people, even if they have the same symptoms you have. It may harm them.

What are the ingredients in ZYKADIA?

Active ingredient: Ceritinib

Inactive ingredients capsules:  Colloidal silicon dioxide, low-substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate. 

Inactive ingredients tablets: Tablet core: colloidal silicon dioxide, croscarmellose sodium, low-substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose and povidone.


Have questions about chemotherapy?

Contact for Second Opinion or Free Counselling

Available 24/7
Experiencing
symotoms that
concern you
Have questions
about cancer?
Just ask Alexa. Find voice-activated answers to 800+ questions on 40+ cancer types.